Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
Clinical trial NCT01387282 · COMPLETED
Trial details
- NCT number
- NCT01387282
- Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-11-01
- Enrollment
- 495
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.